This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.83% per year. These returns cover a period from January 1, 1988 through January 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
CLOV Reports MA Membership Growth, Signals GAAP Profitability in 2026
by Zacks Equity Research
Clover Health posts 53% AEP PPO membership growth, lifts total members to 153,000, and says the momentum positions it for GAAP net income profitability in 2026.
OMCLNegative Net Change ATRCNegative Net Change PAHCNegative Net Change CLOVNegative Net Change
medical medical-devices
Masimo Stock Declines Despite Solid Preliminary Q4 Revenues
by Zacks Equity Research
MASI posts strong fourth-quarter and full-year 2025 preliminary results with revenue and EPS above estimates, driven by core healthcare momentum.
BSXPositive Net Change CAHNegative Net Change MASINegative Net Change IDXXNegative Net Change
earnings medical medical-devices
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
by Zacks Equity Research
QDEL's decent Q3 2025 results and expanding diagnostics portfolio support near-term growth despite respiratory reliance and payer risks.
BSXPositive Net Change IDXXNegative Net Change QDELNegative Net Change STENegative Net Change
medical medical-devices
PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research
by Zacks Equity Research
PACB stock jumps as HiFi whole-genome sequencing becomes first-line in major SUDC research, highlighting adoption momentum.
BSXPositive Net Change IDXXNegative Net Change STENegative Net Change PACBNegative Net Change
medical medical-devices
After Golden Cross, Adeia (ADEA)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
ADEAPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
by Zacks Equity Research
FMS' acquisitions, partnerships and global reach fuel growth, even as rising costs and optimization efforts weigh on near-term performance.
OMCLNegative Net Change FMSNegative Net Change ATRCNegative Net Change PAHCNegative Net Change
medical medical-devices
3 Medical Device Companies in Focus for Monetizing Data and Analytics
by Indrajit Bandyopadhyay
Medtronic, IQVIA and GE HealthCare show how medical device leaders are turning analytics, AI and enterprise data platforms into recurring revenue engines.
MDTNegative Net Change IQVNegative Net Change GEHCNegative Net Change
medical medical-devices
BSX Stock May Gain From Newly Inked Deal to Buy Valencia Technologies
by Zacks Equity Research
Boston Scientific stock may rebound after agreeing to buy Valencia Technologies, adding the FDA-approved eCoin ITNS device to expand its Urology portfolio.
BSXPositive Net Change IDXXNegative Net Change STENegative Net Change NVSTNegative Net Change
medical medical-devices
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
by Zacks Equity Research
WST is riding on surging GLP-1 demand and HVP expansion. Yet, pricing pressure, tariff risks and contract manufacturing headwinds cloud the near-term outlook.
CAHNegative Net Change COONegative Net Change WSTNegative Net Change PAHCNegative Net Change
medical medical-devices
KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery
by Zacks Equity Research
Kestra teams up with Biobeat in an exclusive deal, investing $5M to add continuous blood pressure monitoring to the ASSURE WCD during cardiac recovery.
BSXPositive Net Change ATRCNegative Net Change PAHCNegative Net Change KMTSNegative Net Change
medical medical-devices